Compare New York Times Co (NYT) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
New York Times Co vs Revvity Inc — how do they compare? New York Times Co trades at $75.56 (market cap $12.29B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: New York Times Co and Revvity Inc are close in size by market cap, and New York Times Co pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| NYT | RVTY | |
|---|---|---|
Market Cap | $12.29B | $11.87B |
Sector | Media | Technology |
52-Week High | $85.86 | $117.75 |
52-Week Low | $51.43 | $82.26 |
Enterprise Value | $11.68B | $14.36B |
Dividend Yield | 1.21% | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About New York Times Co
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
